← Open Payments lookup

CHRISTEN DAVIS: Open Payments

NPI 1124344841 · BURKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$494 in 23 payments from 7 companies in 2025. Trend: 2023 $642 · 2024 $671 · 2025 $494

Food & beverage: $494
CompanyPaymentsAmount
GlaxoSmithKline, LLC.9$159
GENZYME CORPORATION3$99
Novartis Pharmaceuticals Corporation4$87
AstraZeneca Pharmaceuticals LP4$86
ARS Pharmaceuticals Operations, Inc.1$27
Amgen Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, Rhapsido, FASENRA, NEFFY, TAKHZYRO.

Industry payments across VA — which companies pay providers there.